Synthesis and Biological Evaluation of 1-Methyl-2-(3′,4′,5′-trimethoxybenzoyl)-3-aminoindoles as a New Class of Antimitotic Agents and Tubulin Inhibitors
Journal of Medicinal Chemistry2008Vol. 51(5), pp. 1464–1468
Citations Over TimeTop 10% of 2008 papers
Romeo Romagnoli, Pier Giovanni Baraldi, Taradas Sarkar, María Dora Carriòn, M Cara, Olga Cruz‐López, Delia Preti, Mojgan Aghazadeh Tabrizi, Manlio Tolomeo, Stefania Grimaudo, Antonella Di Cristina, Nicola Zonta, Jan Balzarini, Andrea Brancale, Hsing‐Pang Hsieh, Ernest Hamel
Abstract
The 2-(3,4,5-trimethoxybenzoyl)-2-aminoindole nucleus was used as the fundamental structure for the synthesis of compounds modified with respect to positions C-4 to C-7 with different moieties (chloro, methyl, or methoxy). Additional structural variations concerned the indole nitrogen, which was alkylated with small alkyl groups such as methyl or ethyl. We have identified 1-methyl-2-(3,4,5-trimethoxybenzoyl)-3-amino-7-methoxyindole as a new highly potent antiproliferative agent that targets tubulin at the colchicine binding site and leads to apoptotic cell death.
Related Papers
- → Interactions of colchicine with tubulin(1991)283 cited
- → Biochemical determination of tubulin-microtubule equilibrium in cultured cells(1979)40 cited
- → B‐ring of colchicine and its role in taxol‐induced tubulin polymerization(1986)4 cited
- → A modified colchicine-binding assay for the measurement of total and microtubule-derived tubulin in rat liver(1983)15 cited
- → Role of B-ring of colchicine in its binding to Zn(II)-induced tubulin-sheets(1987)